Palomino Laboratories (PALX) Equity Ratio (2022 - 2025)

Palomino Laboratories has disclosed Equity Ratio across 4 years of filings, most recently posting 0.96 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.96, up 824.43% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.96 (up 824.43% YoY), and the FY2025 annual result was 0.96, up 824.43% from the prior year.
• Equity Ratio came in at 0.96 for Q4 2025 at Palomino Laboratories, up from 0.88 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.96 in Q4 2025 to a low of 237.01 in Q2 2025.
• The 4-year median for Equity Ratio is 25.91 (2024), against an average of 58.08.
• Peak annual rise in Equity Ratio reached 824.43% in 2025, while the deepest fall reached 3698.75% in 2025.
• Palomino Laboratories' Equity Ratio stood at 55.61 in 2022, then increased by 13.37% to 48.17 in 2023, then soared by 99.72% to 0.13 in 2024, then surged by 824.43% to 0.96 in 2025.
• The last three Equity Ratio figures came in at 0.96 (Q4 2025), 0.88 (Q3 2025), and 237.01 (Q2 2025), per Business Quant data.